Table 1.

Age range and median age at last news from patient in years of the 12 most prevalent PID diagnoses and WAS, XLP, and FHLH (patients with no HSCT or gene therapy), living patients.

12 PIDs, WAS, XLP, FHLH	Male (n)	Female (n)	Total (no HSCT/no gene therapy)		Age range (years)	Median age (years)	Living patients with and withoutHSCT/gene therapy
CVID	313	352	665	99.8%	3–88	40	666
Unclassified antibody deficiency	102	119	221	99.1%	0–80	28	223
CGD	46	12	58	51%	0–59	21	114
Agammaglobulinemia	90	7	97	98%	2–54	17	99
Isolated IgG subclass deficiency	40	42	82	100%	4–68	39	82
SCID	6	2	8	11%	0–21	15	76
Unclassified IDs	22	20	42	93%	3–79	20	45
Combined ID	21	17	38	60%	3–57	18	63
DGS	25	27	52	100%	0–40	8	52
Selective IgA deficiency	17	30	47	100%	3–75	23	47
A-T	30	25	55	96%	3–37	13	57
HIES	28	19	47	85%	0–43	16	55
WAS	7	0	7	25%	0–31	20	28
XLP	14	1	15	68%	7–52	19	22
FHLH	3	0	3	17%	2–13	7	18
Total	763	672	1,437	87%	0–88		1,647